Cerus Corporation (CERS): Company Short-Term Debts

Public company logo of Cerus Inc (CERS)

Cerus Corporation (CERS) minimizes medical threats by developing donor blood purification technologies, ensuring strong product demand across global hospitals. This chart illustrates short-term debt, which currently stands at 0.04. The business's financial stability relies on the INTERCEPT system; consistent procurement of consumables by clinics creates a reliable cash flow, supporting the company's high profitability.

CERS (Cerus) Company Short-Term Debts history from 07/04/2022 to 10/31/2026

Analytical breakdowns for Cerus Inc (CERS)

- stock price and consensus target price:
Stock Price Cerus|CERS - Analyst Median Target
- stock exchange capitalization data:
Market Capitalization Cerus Corporation|CERS - Real Price to Acquire Entire Company
- business book valuation details:
Book Value per Share Cerus|CERS - Book Capitalization|Market Value to Book Value Ratio cerus.com|CERS - Aggregate Company Assets
- debt and liquidity data:
Total Debt to Equity Ratio Cerus Corporation|CERS - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Cerus Corporation|CERS - Company Total Debt Obligations|Debt to Book Capitalization Ratio Cerus Corporation|CERS - Company Long-Term Indebtedness|Company Short-Term Debt Cerus|Quick Liquidity Indicator cerus.com
- net income and valuation multiples indicators:
CERS - Profit After Payment of Taxes
Fundamental company analysis:CERS - Cerus
Flagship merchandise of Cerus Inc

This metric measures the total credit obligations of Cerus Corporation (CERS) with a maturity of up to one year. A decrease in this metric signals high solvency and the minimization of default risks. By analyzing the history of short-term debt, an investor can assess the effectiveness of liquidity management. The current value of 0.04 reflects the company's financial leverage. Optimizing borrowings supports the scaling of blood purification systems, reducing unit costs through operating leverage.

Direct competitors

Intuitive - Company Short-Term Debts|Short-Term Debt Volume Danaher Corporation DHR|BDX: Company Short-Term Debts|Company Current Liabilities STERIS Group|WST (West Pharmaceutical Services) - Company Short-Term Debts|Company Short-Term Debts baxter.com|Company Short-Term Debt Masimo (MASI)|Company Short-Term Debt STVN (Stevanato Group SpA)|Teleflex Inc - Company Current Liabilities|Company Short-Term Loans and Borrowings MMSI|Envista Holdings - Company Short-Term Debts|Short-Term Debt Volume icumed.com ICUI|Dentsply Sirona (XRAY) - Company Short-Term Debt|Company Short-Term Indebtedness LMAT|Company Short-Term Debt AtriCure Corp|STAAR Surgical Co (STAA) - Short-Term Debt Volume|Company Current Liabilities NAGE (ChromaDex)|Amount of Current Liabilities ZIMV|Company Short-Term Debt AngioDynamics ANGO|Company Short-Term Loans and Borrowings TKNO|MGRM: Company Current Liabilities|STSS - Company Short-Term Debts|infusystem.com (INFU) - Company Short-Term Debt|Company Current Liabilities utahmed.com|KRMD (KORU Medical Systems, Inc.) - Company Short-Term Debts|Short-Term Debt Nyxoah SA NYXH|Company Short-Term Debt Microbot Medical Inc (MBOT)|Pro-Dex Inc. - Company Short-Term Indebtedness|Zentek Ltd. - Company Current Liabilities|Amount of Current Liabilities ELUT (elutia.com)|MLSS - Company Short-Term Debt|Short-Term Debt Volume NEXGEL Inc. NXGL|RVP: Company Short-Term Debts|Company Current Liabilities Harvard Bioscience Inc.|FEMY (Femasys Inc.) - Company Short-Term Debts|Short-Term Debt Meihua Medical MHUA|Company Short-Term Debt Predictive Oncology (POAI)|CJMB (callanjmb.com) - Company Short-Term Loans and Borrowings|Atrion Corp - Company Current Liabilities|Company Short-Term Debts NeuroMetrix Corporation NURO